New Brunswick Scientific Co., Inc. (NBSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: richardred	10/28/2004 12:18:17 AM
	Read Replies (2) of 724

TMO-A good sign Revenue from the life and laboratory sciences division was boosted by new products, soaring 27 percent to $383 million while measurement and control sales jumped 9 percent to $159 million on the back of strong demand from customers in the materials industry. "We've made significant internal investments to develop new products, expand our services and create the commercial framework necessary to differentiate Thermo in the marketplace," said CEO Marijn Dekkers. "We also have the resources to continue to make strategic acquisitions that extend our offerings and market coverage. For the fourth quarter, Thermo Electron pegged earnings in a range of 36 cents to 38 cents a share. Analysts previously forecast a profit of 38 cents a share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next